Robert Abernathy

Robert E.
Abernathy currently serves as Independent Director at Haemonetics Corp.
since 2017 and at Avient Corp.
since 2018.
He is also a Director at Fox Cities Performing Arts Center, Inc. and World Vision, Inc., and a Member of the Leadership Board at the College of Arts & Sciences (Al).
Formerly, Mr. Abernathy was Chairman at Avanos Medical, Inc. in 2017, Director at The Lubrizol Corp.
from 2006 to 2011, Independent Director at RS Legacy Corp., Director at Kimberly-Clark de México SAB de CV, Managing Director at Kimberly-Clark Australia Pty Ltd., Director at Advanced Medical Technology Association, President-Global Health at Kimberly-Clark Corp.
in 2014, and Principal at Kimberly-Clark Health Care, Inc. in 2004.
Education includes graduate degrees from Lawrence University (1978) and the Institute of Paper Chemistry, and an undergraduate degree from The University of Alabama (1976).